Aziyo Biologics Inc reports results for the quarter ended in June - Earnings Summary

Elutia

14/08/2023 22:52

* Aziyo Biologics Inc  AZYO.OQ  reported a quarterly
adjusted loss
of 65 cents​​ per share for the quarter ended in June. The lone
analyst forecast for the quarter was for a loss of 29 cents per
share.
    * Revenue fell 18.5% to $10.30 million from a year ago;
analysts
expected $12.50 million. 
    * Aziyo Biologics Inc's reported EPS for the quarter was a
loss
of 65 cents​.
    * The mean earnings estimate of analysts had risen by
about 17.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Aziyo Biologics Inc shares had fallen by 41.5% this
quarter and
lost 67.5% so far this year.
    * The company reported a quarterly loss of $10.62 million.
    * Wall Street's median 12-month price target for Aziyo
Biologics
Inc is $8.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 14 at 09:51 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.29          -0.65          Missed
 Mar. 31 2023      -0.54          -0.49          Beat
 Dec. 31 2022      -0.69          -0.38          Beat
 Sep. 30 2022      -0.66          -0.73          Missed